Breckenridge Pharmaceutical, Inc. is a privately-held own label Distributor that performs pharmaceutical research and development as well as marketing and distribution in the U.S. The company was founded in 1983, and markets a broad range of generic prescription products in many therapeutic categories.
The Breckenridge label is recognized by Retail Pharmacy Chains, Mail Order Pharmacies, Pharmacy Benefit Managers and Group Purchasing Organizations as well as Wholesalers and Distributors throughout the United States.
We market in excess of 50 products in a variety of dosage forms including: tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmics, nasal sprays and powders. Our pipeline includes:Injectables, Transdermals, Inhalers and Topicals.
Breckenridge, with company offices in Berlin, CT - Boca Raton, FL and New York City - has 30 approved Abbreviated New Drug Applications (ANDA's) and over 40 ANDA's that have been filed and are pending approval from the Food and Drug Administration (FDA).
we create opportunity